To include your compound in the COVID-19 Resource Center, submit it here.

Eligo raises $20M series A

Microbiome company Eligo Bioscience S.A.S. (Paris, France) raised $20 million in a series

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE